Topic: procardia

Introduction: Beyond the Serotonin Hypothesis For decades, the treatment of depression and anxiety disorders was dominated by medications targeting a single neurotransmitter: serotonin. Selective Serotonin Reuptake Inhibitors (SSRIs) like fluoxetine (prozac [https://rache.es]) and sertraline (Zoloft) became household names. However, a significant portion of patients did not achieve full remission with these agents, leading to the development of a different class of drugs with a dual mechanism o...